[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.] [@SonaNanotech](/creator/twitter/SonaNanotech) "$SONA $SNANF recently presented at #ASCO2025. This milestone follows our publication in Frontiers in Immunology ranked in the top XX% of all articles from the journal. You can catch the key moments in this extract from our recent webinar:" [X Link](https://x.com/SonaNanotech/status/1935729306316988909) [@SonaNanotech](/creator/x/SonaNanotech) 2025-06-19T16:00Z 3126 followers, XXX engagements "$SONA $SNANF Episode X of Carmans Corner is live Dr. Carman unpacks how our immune system detects and responds to cancer highlighting the crucial roles of both the innate and adaptive arms. Curious about how your bodys natural defenses work together Watch now" [X Link](https://x.com/SonaNanotech/status/1938633210843267558) [@SonaNanotech](/creator/x/SonaNanotech) 2025-06-27T16:19Z 3126 followers, XXX engagements "What if cancer immunotherapy response rates could be improved by just XX% In this webinar clip our team discusses the potential impact of $SONA $SNANF gold nanorod THT therapy across multiple cancer types:" [X Link](https://x.com/SonaNanotech/status/1940438933399101732) [@SonaNanotech](/creator/x/SonaNanotech) 2025-07-02T15:54Z 3126 followers, XXX engagements "$SONA $SNANF announces that a first dosing has been achieved in the previously announced early feasibility study of its Targeted Hyperthermia Therapy cancer treatment. Read the full news release" [X Link](https://x.com/SonaNanotech/status/1942216795676422653) [@SonaNanotech](/creator/x/SonaNanotech) 2025-07-07T13:39Z 3126 followers, XXX engagements "Catch the latest Proactive Investors interview recapping our recent milestone: dosing the first patient in our Targeted Hyperthermia Therapy trial for advanced melanoma. Hear from CEO David Regan on whats next for $SONA $SNANF:" [X Link](https://x.com/SonaNanotech/status/1942593594990182633) [@SonaNanotech](/creator/x/SonaNanotech) 2025-07-08T14:36Z 3126 followers, XXX engagements "Get insights on $SONA $SNANF & the progress with their first-in-human cancer treatment clinical trial in this replay of yesterday's webinar. Hear directly from their CEO & CMO as well as an expert panelist.:" [X Link](https://x.com/SonaNanotech/status/1946214491848319317) [@SonaNanotech](/creator/x/SonaNanotech) 2025-07-18T14:24Z 3126 followers, XXX engagements "$SONA CEO David Regan joins 3500+ medtech leaders at #MedTechConference sponsored by Abbott BD Johnson & Johnson MedTech and Medtronic. Sonas THT is redefining cancer treatment with a gentle immune-activating nanotechnology. #MedTech #Nanomedicine #SonaNanotech" [X Link](https://x.com/SonaNanotech/status/1975280750405587183) [@SonaNanotech](/creator/x/SonaNanotech) 2025-10-06T19:23Z 3126 followers, XXX engagements
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
@SonaNanotech
"$SONA $SNANF recently presented at #ASCO2025. This milestone follows our publication in Frontiers in Immunology ranked in the top XX% of all articles from the journal. You can catch the key moments in this extract from our recent webinar:"
X Link @SonaNanotech 2025-06-19T16:00Z 3126 followers, XXX engagements
"$SONA $SNANF Episode X of Carmans Corner is live Dr. Carman unpacks how our immune system detects and responds to cancer highlighting the crucial roles of both the innate and adaptive arms. Curious about how your bodys natural defenses work together Watch now"
X Link @SonaNanotech 2025-06-27T16:19Z 3126 followers, XXX engagements
"What if cancer immunotherapy response rates could be improved by just XX% In this webinar clip our team discusses the potential impact of $SONA $SNANF gold nanorod THT therapy across multiple cancer types:"
X Link @SonaNanotech 2025-07-02T15:54Z 3126 followers, XXX engagements
"$SONA $SNANF announces that a first dosing has been achieved in the previously announced early feasibility study of its Targeted Hyperthermia Therapy cancer treatment. Read the full news release"
X Link @SonaNanotech 2025-07-07T13:39Z 3126 followers, XXX engagements
"Catch the latest Proactive Investors interview recapping our recent milestone: dosing the first patient in our Targeted Hyperthermia Therapy trial for advanced melanoma. Hear from CEO David Regan on whats next for $SONA $SNANF:"
X Link @SonaNanotech 2025-07-08T14:36Z 3126 followers, XXX engagements
"Get insights on $SONA $SNANF & the progress with their first-in-human cancer treatment clinical trial in this replay of yesterday's webinar. Hear directly from their CEO & CMO as well as an expert panelist.:"
X Link @SonaNanotech 2025-07-18T14:24Z 3126 followers, XXX engagements
"$SONA CEO David Regan joins 3500+ medtech leaders at #MedTechConference sponsored by Abbott BD Johnson & Johnson MedTech and Medtronic. Sonas THT is redefining cancer treatment with a gentle immune-activating nanotechnology. #MedTech #Nanomedicine #SonaNanotech"
X Link @SonaNanotech 2025-10-06T19:23Z 3126 followers, XXX engagements
/creator/twitter::2257923222/posts